TIAA CREF Investment Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-90,243
| Closed | -$334K | – | 3096 |
|
|
2017
Q4 | $334K | Sell |
90,243
-5,863
| -6% | -$21.7K | ﹤0.01% | 2916 |
|
|
2017
Q3 | $393K | Buy |
96,106
+2,578
| +3% | +$10.5K | ﹤0.01% | 2933 |
|
|
2017
Q2 | $347K | Buy |
+93,528
| New | +$347K | ﹤0.01% | 3000 |
|
|
2016
Q2 | – | Sell |
-52,700
| Closed | -$402K | – | 3233 |
|
|
2016
Q1 | $402K | Hold |
52,700
| – | – | ﹤0.01% | 2845 |
|
|
2015
Q4 | $702K | Buy |
52,700
+8,349
| +19% | +$111K | ﹤0.01% | 2774 |
|
|
2015
Q3 | $729K | Sell |
44,351
-6,497
| -13% | -$107K | ﹤0.01% | 2748 |
|
|
2015
Q2 | $1.14M | Buy |
50,848
+4,736
| +10% | +$106K | ﹤0.01% | 2630 |
|
|
2015
Q1 | $451K | Hold |
46,112
| – | – | ﹤0.01% | 2952 |
|
|
2014
Q4 | $526K | Buy |
46,112
+3,366
| +8% | +$38.4K | ﹤0.01% | 2950 |
|
|
2014
Q3 | $492K | Sell |
42,746
-1,439
| -3% | -$16.6K | ﹤0.01% | 2976 |
|
|
2014
Q2 | $859K | Buy |
+44,185
| New | +$859K | ﹤0.01% | 2807 |
|
|
2013
Q3 | – | Sell |
-931
| Closed | -$9K | – | 3132 |
|
|
2013
Q2 | $9K | Buy |
+931
| New | +$9K | ﹤0.01% | 3092 |
|